IRIS
LODI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.448
EU - Europa 3.627
AS - Asia 1.643
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
SA - Sud America 3
Totale 9.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.361
CN - Cina 1.229
IE - Irlanda 805
SE - Svezia 671
IT - Italia 587
FI - Finlandia 537
UA - Ucraina 478
DE - Germania 332
SG - Singapore 241
TR - Turchia 126
GB - Regno Unito 91
CA - Canada 85
FR - Francia 36
BE - Belgio 32
NL - Olanda 15
ES - Italia 13
IN - India 12
CZ - Repubblica Ceca 9
CI - Costa d'Avorio 8
EU - Europa 7
HK - Hong Kong 6
IR - Iran 6
VN - Vietnam 6
JP - Giappone 5
PH - Filippine 5
RO - Romania 4
RU - Federazione Russa 4
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
KR - Corea 3
MK - Macedonia 2
NG - Nigeria 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ID - Indonesia 1
LV - Lettonia 1
MC - Monaco 1
ME - Montenegro 1
MX - Messico 1
RS - Serbia 1
Totale 9.745
Salva come PNG Salva come JPEG
Città #
Dublin 793
Chandler 791
Jacksonville 537
Ashburn 297
Ann Arbor 282
Dearborn 282
Beijing 257
Boardman 226
Nanjing 209
Parma 176
Princeton 155
Singapore 146
San Mateo 132
Izmir 123
Wilmington 118
Shanghai 103
Jinan 74
Toronto 73
New York 71
Shenyang 70
Nanchang 61
Los Angeles 56
Hefei 55
Des Moines 54
Kunming 51
Helsinki 50
Woodbridge 50
Hebei 48
Santa Clara 39
Brussels 30
Falls Church 30
Jiaxing 30
Guangzhou 29
Dosolo 26
Tianjin 25
Changsha 24
Seattle 23
Houston 20
Redmond 18
Zhengzhou 17
Bremen 16
Haikou 16
Padova 15
Fremont 14
Fuzhou 14
Hangzhou 14
Taizhou 13
Bologna 12
Modena 11
Norwalk 11
Redwood City 11
Lanzhou 10
Rockville 10
Auburn Hills 9
Dallas 9
Rome 9
Abidjan 8
Almería 8
Borås 8
Milan 8
Phoenix 8
Chongqing 7
Grafing 7
Gravina di Catania 7
Xian 7
Amsterdam 6
Cordovado 6
Dong Ket 6
Messina 6
Pavia 6
Pune 6
Sorbolo 6
Taiyuan 6
Wenzhou 6
Wuhan 6
Davao City 5
Düsseldorf 5
Fairfield 5
Piacenza 5
Scafati 5
Ardea 4
Avola 4
Brescia 4
Dronten 4
Frankfurt am Main 4
Las Vegas 4
London 4
Madrid 4
Montreal 4
Perugia 4
Quzhou 4
San Remo 4
Vancouver 4
Washington 4
Zanjan 4
Afragola 3
Cairo 3
Cambridge 3
Cesenatico 3
Este 3
Totale 6.073
Salva come PNG Salva come JPEG
Nome #
DNA polymerase [gamma] and disease: what we have learned from yeast 110
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of DNA polymerase gamma allelic variants 101
A chemical genomic approach to characterize the antiproliferative activity of metal based drugsdriven by phenotypic screening in yeast as a model organism 101
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 99
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 98
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 98
Yeast, worm, patient’s fibroblasts and zebrafish as models for drug repositioning of molecules targeting POLG-related diseases 98
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 94
A Klaac null mutant of Kluyveromyces lactis is complemented by a single copy of the Saccharomyces cerevisiae AAC1 gene 94
IMP2, a nuclear gene controlling the mitochondrial dependence of galactose, maltose and raffinose utilization in Saccharomyces cerevisiae. 92
Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island 92
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 91
S. cerevisiae carrying a MGM1/OPA1 chimeric gene: a model for the study of dominant optic atrophy and for drug discovery 91
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 90
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 88
Behaviour of Saccharomyces cerevisiae wine strains during adaptation to unfavourable conditions of fermentation on synthetic medium: Cell lipid composition, membrane integrity, viability and fermentative activity 88
In vitro evaluation of the activity of thiosemicarbazone derivatives against mycotoxigenic fungi affecting cereals 88
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations 88
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 87
Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study 87
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 87
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models 87
Screening of thiosemicarbazones as antimycotic drugs 86
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of Clofilium tosylate as a potential therapeutic chemical against POLG-related diseases 85
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 85
Characterization of a promoter mutation in the CYP3 gene of S. cerevisiae which cancels regulation by Cyp1p (Hap1p) without affecting its binding site 84
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 83
Construction and validation of a yeast model system for studying in vivo the susceptibility to stavudine of Polg allelic variants 81
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 81
COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES 81
Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy 81
Secretion of human serum albumin from Kluyveromyces lactis over-expressing KlPDI1 and KlERO1 genes 80
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 80
Structural modification of cuminaldehyde thiosemicarbazone increases inhibition specificity toward aflatoxin biosynthesis and sclerotia development in Aspergillus flavus 80
Cloning and characterization of the lactate-specific inducible gene KlCYB2, encoding the cytochrome b2 of Kluyveromyces lactis 79
Amino and carboxy-terminal extensions of yeast mitochondrial DNA polymerase assemble both the polymerization and exonuclease active sites 79
Klaac null mutant in K. lactis is complemented by a single copy of S. cerevisiae “silent” gene AAC1 78
A chemical genomic approach to characterize the antiproliferative activity of metal-based drugs driven by phenotipic screening in yeast as a model organism 78
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 78
Catabolite repression by galactose in overexpressed GAL4 strains of Saccharomyces cerevisiae 76
Chiral Aminoacid Containing Acyclic Ligands. I. Syntheses and Conformations 76
Allelism of IMP1 and GAL2 genes of Saccharomyces cerevisiae 76
A mitochondrial role in pseudohyphal constitutive mutants obtained from a natural Saccharomyces cerevisiae strain 75
“Espressione e secrezione di una Major Urinary Protein di topo nel lievito metilotrofo Pichia pastoris” 75
Construction of a yeast model system for studying in vivo susceptibility to stavudine of Polg allelic variants 73
Overexpression of DNA Polymerase Zeta Reduces the Mitochondrial Mutability Caused by Pathological Mutations in DNA Polymerase Gamma in Yeast 73
LYS2 gene and its mutation in Kluyveromyces lactis 72
“Expression and structural characterization of a recombinant mouse major urinary protein” 72
Construction and characterization of centromeric, episomal and GFP-containing vectors for Saccharomyces cerevisiae prototrophic strains 72
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 72
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 71
Elementi regolativi implicati nel processo di repressione /derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 70
“Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein” 70
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 70
Effetti fenotipici e funzionali di mutazioni del gene ANT1 responsabili della patologia umana adPEO nel lievito Saccharomyces cerevisiae 69
L'aumento del dosaggio del gene ero1 favorisce la secrezione di proteine ricombinanti in Kluyveromyces lactis 69
Expression of a lipocalin in Pichia pastoris: secretion, purification and binding activity of a recombinant Major Urinary Protein 69
Regolazione del gene JEN1, codificante la lattato permeasi, nel lievito Saccharomyces cerevisiae 68
Construction and validation of a yeast model system for studying in vivo the susceptibility to nucleoside analogues of DNA polymerase gamma allelic variants. 68
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 68
Modeling of pathogenic variants of mitochondrial DNA polymerase: insight into the replication defects and implication for human disease 67
Comparative Functional Genomics of glucose repression in laboratory and wine yeasts 66
Carbon catabolite repression in Kluyveromyces lactis: isolation and characterization of the KlDLD gene encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. 66
Investigation of mupirocin susceptibility in bifidobacteria: physiological and genetic insights. 66
MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of IMP2p 65
A variable neurodegenerative phenotype with polymerase gamma mutation 65
Carboxylic acids permeases in yeast: two genes in Kluyveromyces lactis.” 65
Overexpression of DNA polymerase zeta and Rev1 reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 64
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 64
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 64
Yeast as a model for drug discovery: Identification of a molecule acting as potential therapeutics for POLG-related diseases 64
Klaac null mutant in K.lactis is complemented by a single copy of S.cerevisiae gene AAC1 63
Characterization of KlGUT2, a gene of the glycerol-3-phosphate shuttle, in Kluyveromyces lactis 63
Rescue by Pol zeta overexpression of mitochondrial DNA instability due to mutations in Pol gamma in S. cerevisiae 63
Antimycin- and hydroxamate-insensitive respiration in yeast 63
Overexpression of DNA polymerase zeta reduces the mitochondrial mutability caused by pathological mutations in DNA polymerase gamma in yeast. 63
Klaac null mutant in Kluyveromycs lactis is complemented by a single copy of Saccharomyces cerevisiae gene AAC1 63
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 63
The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. 62
Influence of leucine metabolism on Saccharomyces cerevisiae dimorphism 61
Yeast as a model for drug discovery: identification of a molecule acting as potential therapeutics for POLG-related diseases 61
Identificazione dei bersagli della proteina Imp2p in Saccharomyces cerevisiae 60
“MAJOR URINARY PROTEINS: STUDIES ON THE BINDING OF FLUORESCENT MOLECULES AND ITS 13C AND 15N ENRICHED EXPRESSION IN PICHIA PASTORIS” 60
Galactose transport in Kluyveromyces lactis: a genomic approach 60
Lipid Metabolism Related To Stuck Fermentation In Saccharomyces cerevisiae Wine Strains 59
Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1 59
Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish 59
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 59
Modification of nuclear gene expression by inhibition of mitochondrial translation during sporulation in MATa/Mata diploids of Saccharomyces cerevisiae. 58
Co-ordinated regulation of lactate metabolism genes in yeast: role of lactate permease gene JEN1 58
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 57
Il lievito come modello per lo studio di patologie mitocondriali umane 57
Yeast as a model for drug repositioning: analysis of molecules acting as potential therapeutics for POLG-related diseases 57
Il metabolismo lipidico di ceppi vinari di Saccharomyces cerevisiae e gli arresti di fermentazione 57
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 57
“La proteina feromonale Major Urinary Protein: struttura della proteina ricombinante ed indagini molecolari sull’organo sensoriale del sistema olfattivo feromonale” 56
Elementi regolativi implicati nel processo di repressione/derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 56
FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis are homologous to GAL83 and SNF1 of Saccharomyces cerevisiae 56
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 56
Three target genes for the transcriptional activator Cat8p of Kluyveromyces lactis: acetyl coenzyme A synthetase genes KlACS1 and KlACS2 and lactate permease gene KlJEN1 56
Totale 7.370
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.445 0 0 134 20 162 237 257 61 239 170 44 121
2020/20211.141 22 119 111 26 154 40 138 45 229 41 172 44
2021/2022787 22 16 15 36 25 24 103 120 34 67 50 275
2022/20232.873 312 276 217 220 232 329 28 193 934 18 87 27
2023/20241.028 54 86 33 30 89 241 85 112 15 88 80 115
2024/2025385 36 176 173 0 0 0 0 0 0 0 0 0
Totale 9.971